Epilepsy, osteoporosis and fracture risk - A meta-analysis

Acta Neurologica Scandinavica

Volumn 112, Issue 5, 2005, Pages 277-286

  Vestergaard, Peter ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Epilepsy; Fracture; Meta analysis; Osteoporosis; Risk

Indexed keywords

ARTICLE; BONE DENSITY; CALCULATION; CLINICAL TRIAL; DISEASE ASSOCIATION; EPILEPSY; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; INFORMATION RETRIEVAL; MEDICAL ASSESSMENT; MEDICAL DOCUMENTATION; MEDLINE; META ANALYSIS; OSTEOPOROSIS; RISK ASSESSMENT; SCORING SYSTEM; SEIZURE; SPINE FRACTURE; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW;

ANTICONVULSANTS; BONE DENSITY; EPILEPSY; FRACTURES, SPONTANEOUS; HUMANS; OSTEOPOROSIS; RISK;

EID: 27444437767     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00474.x     Document Type: Article

References (74)

1. LIDGREN L, NILSSON BE, WALLÖE A. Bone mineral content in epileptics. Calcif Tissue Int 1979;28:99-102.
2. LIDGREN L, WALLOE A. Incidence of fracture in epileptics. Acta Orthop Scand 1977;48:356-61.
3. VESTERGAARD P, TIGARAN S, REJNMARK L, TIGARAN C, DAM M, MOSEKILDE L. Fracture risk is increased in epilepsy. Acta Neurol Scand 1999;99:269-75.
4. SHETH RD, WESOLOWSKI CA, JACOB JC et al. Effect of carbamazepine and valproate on bone mineral density. J Pediatr 1995;127:256-62.
5. ABOUKASM AG, SMITH BJ. Nocturnal vertebral compression fracture. A presenting feature of unrecognized epileptic seizures. Arch Fam Med 1997;6:185-7.
6. KRISTIANSEN B, CHRISTENSEN S. Fractures of the proximal end of the humerus caused by convulsive seizures. Injury 1984;16:108-9.
7. ELBERGER ST, BRODY G. Bilateral posterior shoulder dislocations. Am J Emerg Med 1995;13:331-2.
8. MCGLONE R, GOSNOLD JK. Posterior dislocation of shoulder and bilateral hip fractures caused by epileptic seizure. Arch Emerg Med 1987;4:115-6.
9. GRANHED HP, KARLADANI A. Bilateral acetabular fracture as a result of epileptic seizure: a report of two cases. Injury 1997;28:65-8.
10. MOSEKILDE L, HANSEN HH, CHRISTENSEN MS et al. Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy: short term effects of 1,25-dihydroxychole-calciferol and 25-hydroxycholecalciferol. Acta Med Scand 1979;205:405-9.
11. MOSEKILDE L, MELSEN F. Dynamic differences in trabecular bone remodeling between patients after jejuno-ileal bypass for obesity and epileptic patients receiving anticonvulsant therapy. Metab Bone Dis Rel Res 1980;2:77-82.
12. CHRISTIANSEN C, KRISTENSEN M, RODBRO P. Latent osteomalacia in epileptic patients on anticonvulsants. Br Med J 1972;3:738-9.
13. CHRISTIANSEN C, RODBRO P, LUND M. Effect of vitamin D on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants: a controlled therapeutic trial. Br Med J 1973;2:208-9.
14. CHRISTIANSEN C, RODBRO P. Initial and maintenance dose of vitamin D2 in the treatment of anticonvulsant osteomalacia. Acta Neurol Scand 1974;50:631-41.
15. CHRISTIANSEN C, RODBRO P, MUNCK O. Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia. Br Med J 1975;2:363-5.
16. CHRISTIANSEN C, RODBRO P, NIELSEN CT. Iatrogenic osteomalacia in epileptic children. A controlled therapeutic trial. Acta Paediatr Scand 1975;64:219-24.
17. CHRISTIANSEN C, BRANDT NJ, EBBESEN F, SARDEMANN H, TROLLE D. Bone mineral content during pregnancy in epileptics on anticonvulsant drugs and in their newborns. Acta Obstet Gynecol Scand 1981;60:501-3.
18. CHRISTIANSEN C, RODBRO P, TIELLESEN L. Pathophysiology behind anticonvulsant osteomalacia. Acta Neurol Scand Suppl 1983;94:21-8.
19. PARFITT AM. Osteomalacia and related disorders. In: Avioli L, Krane SM, eds. Metabolic bone disease and clinically related disorders. San Diego, CA: Academic Press, 2001;327-86.
20. MOSEKILDE L, MELSEN F. Anticonvulsant osteomalacia determined by quantitative analysis of bone changes. Population study and possible risk factors. Acta Med Scand 1976;199:349-55.
21. ALEXEEVA L, BURKHARDT P, CHRISTIANSEN C et al. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO Study Group. Geneva: WHO Technical Report Series 843, 1994;1-129.
22. BURR DB, TURNER CH. Biomechanics of bone. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. Washington: ASBMR, 2003;58-64.
23. HAHN TJ, SCHARP CR, RICHARDSON CA, HALSTEAD LR, KAHN AJ. Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro. J Clin Invest 1978;62:406-14.
24. TAKAHASHI A, ONODERA K, SHINODA H, MAYANAGI H. Phenytoin and its metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, show bone resorption in cultured neonatal mouse calvaria. Jpn J Pharmacol 2000;82:82-4.
25. CHAPUY MC, ARLOT ME, DUBOEUF F et al. Vitamin D, and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-42.
26. DESAI KB, RIBBANS WJ, TAYLOR GJ. Incidence of five common fracture types in an institutional epileptic population [see comments]. Injury 1996;27:97-100.
27. VESTERGAARD P, REJNMARK L, MOSEKILDE L. Fracture risk associated with use of anti-epileptic drugs. Epilepsia 2004;45:1330-7.
28. BLAKE GM, WAHNER HW, FOGELMAN I. The evaluation of osteoporosis: dual energy X-ray absorptiometry and ultrasound in clinical practice. London: Martin Dunitz, 1999;1-470.
29. MARSHALL D, JOHNELL O, WEDEL H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254-9.
30. BOHNING D. Computer-assisted analysis of mixtures and applications: meta-analysis, disease mapping and others. Boca Raton. FL: Chapman & Hall/CRC, 2000;1-232.
31. PERSSON HBI, ALBERTS KA, FARAHMAND BY, TOMSON T. Risk of extremity fractures in adult outpatients with epilepsy. Epilepsia 2002;43:768-72.
32. JORGENSEN L, JACOBSEN BK, WILSGAARD T, MAGNUS JH. Walking after stroke: does it matter? Changes in bone mineral density within the first 12 months after stroke. A longitudinal study. Osteoporos Int 2000;11:381-7.
33. RAMNEMARK A, NYBERG L, BORSSÉN B, OLSSON T, GUSTAFSON Y. Fractures after stroke. Osteoporos Int 1998;8:92-5.
34. VAN STAA TP, LEUFKENS HGM, ABENHAIM L, ZHANG B, COOPER C. Use of oral corticosteroids and risk of fractures. J Bone Mineral Res 2000;15:993-1000.
35. ENSRUD KE, BLACKWELL TL, MANGIONE CM et al. Central nervous system - active medications and risk for falls in older women. J Am Geriatr Soc 2002;50:1629-37.
36. BLACK DM, CUMMINGS SR, KERPF DB et al. Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996;348:1535-41.
37. AKIN R, OKUTAN V, SARICI U, ALTUNBAS A, GOKCAY E. Evaluation of bone mineral density in children receiving antiepileptic drugs. Pediatr Neurol 1998;19:129-31.
38. ERBAYAT AE, SERDAROGLU A, TUMER L, GUCUYENER K, HASANOGLU A. Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab 2001;13:933-9.
39. CHUNG S, AHN C. Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain Dev 1994;16:382-5.
40. STEPHEN LJ, MCLELLAN AR, HARRISON JH et al. Bone density and antiepileptic drugs: a case-controlled study. Seizure 1999;8:339-42.
41. KAFALI G, ERSELCAN T, TANZER F. Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr (Phila) 1999;38:93-8.
42. SHETH RD, WESOLOWSKI CA, JACOB JC et al. Effect of carbamazepine and valproate on bone mineral density [see comments]. J Pediatr 1995;127:256-62.
43. GUO CY, RONEN GM, ATKINSON SA. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia 2001;42:1141-7.
44. FISCHER MH, ADKINS WN JR, LIEBL BH, VANCALCAR SC, MARLETT JA. Bone status in nonambulant, epileptic, institutionalized youth. Improvement with vitamin D therapy. Clin Pediatr (Phila) 1988;27:499-505.
45. HAHN TJ, HALSTEAD LR. Anticonvulsant drug-induced osteomalacia: alterations in mineral metabolism and response to vitamin D3 administration. Calcif Tissue Int 1979;27:13-8.
46. JEKOVEC-VRHOVSEK M, KOCIJANCIC A, PREZELJ J. Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care. Dev Med Child Neurol 2000;42:403-5.
47. TJELLESEN L, GOTFREDSEN A, CHRISTIANSEN C. Effect of vitamin D2 and D3 on bone-mineral content in carbamazepine-treated epileptic patients. Acta Neurol Scand 1983;68:424-8.
48. JONES S, JOHANSEN A, BRENNAN J, BUTLER J, LYONS RA. The effect of socioeconomic deprivation on fracture incidence in the United Kingdom. Osteoporosis Int 2004;15:520-4.
49. LAURITZEN JB, PETERSEN MM, LUND B. Effect of external hip protectors on hip fractures. Lancet 1993;341:11-3.
50. PAPADIMITROPOULOS E, WELLS G, SHEA B et al. Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 2002;23:560-9.
51. SHEA B, WELLS G, CRANNEY A et al. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr Rev 2002;23:552-9.
52. CRANNEY A, WELLS G, WILLAN A et al. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr Rev 2002;23:508-16.
53. CRANNEY A, TUGWELL P, ADACHI J et al. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr Rev 2002;23:517-23.
54. CRANNEY A, GUYATT G, KROLICKI N et al. A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis. Osteoporos Int 2001;12:140-51.
55. CRANNEY A, TUGWELL P, ZYTARUK N et al. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev 2002;23:524-8.
56. MEUNIER PJ, SLOSMAN DO, DELMAS PD et al. Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis - a 2-year randomized placebo controlled trial. J Clin Endocrinol Metab 2002;87:2060-6.
57. REGINSTER JY, MEUNIER PJ. Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies. Osteoporos Int 2003;14(Suppl. 3):56-65.
58. NEER RM, ARNAUD CD, ZANCHETTA JR et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.
59. LEIB ES, LEWIECKI EM, BRINKLEY N, HAMDY RC. Official positions of the International Society for Clinical Densitometry. J Clin Densitom 2004;7:1-6.
60. JANCAR J, JANCAR MP. Age-related fractures in people with intellectual disability and epilepsy. J Intellect Disabil Res 1998;42:429-33.
61. GAITATZIS A, CARROLL K, MAJEED A, SANDER W. The epidemiology of the comorbidity of epilepsy in the general population. Epilepsia 2004;45:1613-22.
62. ANNEGERS JF, MELTON LJ III, SUN C, HAUSER WA. Risk of age-related fractures in patients with unprovoked seizures. Epilepsia 1989;30:348-55.
63. CUMMINGS SR, NEVITT MC, BROWNER WS et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med 1995;332:767-73.
64. KELSEY JL, PRILL MM, KEEGAN TH et al. Reducing the risk for distal forearm fracture: preserve bone mass, slow down, and don't fall! Osteoporos Int 2005;16:681-90.
65. SCANE AC, FRANCIS RM, SUTCLIE AM, FRANCIS MJ, RAWLINGS DJ, CHAPPLE CL. Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men. Osteoporos Int 1999;9:91-7.
66. KOPPEL BS, HARDEN CL, NIKOLOV BG, LABAR DR. An analysis of lifetime fractures in women with epilepsy. Acta Neurol Scand 2005;111:225-8.
67. FILARDI S, GUERREIRO CA, MAGNA LA, MARQUES NJ. Bone mineral density, vitamin D and anticonvulsant therapy. Arq Neuropsiquiatr 2000;58:616-20.
68. VäLIMäKI MJ, TIIHONEN M, LAITINEN K et al. Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Mineral Res 1994;9:631-7.
69. KUBOTA F, KIFUNE A, SHIBATA N et al. Bone mineral density of epileptic patients on long-term antiepileptic drug therapy: a quantitative digital radiography study. Epilepsy Res 1999;33:93-7.
70. FARHAT G, YAMOUT B, MIKATI MA, DEMIRJIAN S, SAWAYA R, EL HAJJ FG. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348-53.
71. ONER N, KAYA M, KARASALIHOGLU S, KARACA H, CELTIK C, TUTUNCULER F. Bone mineral metabolism changes in epileptic children receiving valproic acid. J Paediatr Child Health 2004;40:470-3.
72. PACK AM, OLARTE LS, MORRELL MJ, FLASTER E, RESOR SR, SHANE E. Bone mineral density in an outpatient population receiving enzyme-inducing antiepileptic drugs. Epilepsy Behav 2003;4:169-74.
73. TSUKAHARA H, KIMURA K, TODOROKI Y et al. Bone mineral status in ambulatory pediatric patients on long-term antiepileptic drug therapy. Pediatr Int 2002;44:247-53.
74. TIMPERLAKE RW, COOK SD, THOMAS KA et al. Effects of anticonvulsant drug therapy on bone mineral density in a pediatric population. J Pediatr Orthop 1988;8:467-70.